Halozyme Therapeutics Inc (NASDAQ:HALO)

22.10
Delayed Data
As of Jul 02
 -0.40 / -1.78%
Today’s Change
7.51
Today|||52-Week Range
23.16
+129.02%
Year-to-Date

Today’s Trading

Previous close22.50
Today’s open22.44
Day’s range21.63 - 22.47
Volume992,983
Average volume (3 months)1,367,282
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+12.57%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book67.19

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+1.57+2.47%
NVAXNovavax Inc-0.12-1.09%
RDUSRadius Health Inc+0.99+1.48%
CTLTCatalent Inc-0.10-0.34%
Data as of 4:01pm ET, 07/02/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers